Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists

Gyorgy Bagdy, Alan F. Sved, Dennis L. Murphy, Katalin Szemeredi

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Serotonergic drugs with 5-HT2 receptor agonist properties have been suggested to increase plasma vasopressin concentration, blood pressure (BP) and plasma renin activity (PRA). To study whether these actions are mediated by the same or different receptors, we used three potent 5-HT agonists with different structures and receptor binding profiles. All drugs were administered i.v. to conscious, unrestrained rats. The selective agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), which has high affinity for 5-HT2 receptors, caused marked increases in BP and PRA but no change in plasma vasopressin concentrations. The 5-HT1C agonist, m-chlorophenylpiperazine (m-CPP), which also binds to other 5-HT receptors, caused moderate increases in BP and PRA and significantly elevated plasma vasopressin concentrations. The 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), did not increase any of these parameters. BP and PRA elevations paralleled each other after all drugs, while vasopressin responses were clearly different. Vasopressin responses to m-CPP were entirely antagonised by the 5-HT1/5-HT2 antagonist metergoline, partially by the 5-HT2/5-HT1C antagonists ritanserin and LY 53857, but not by the 5-HT2 antagonist ketanserin. Ritanserin, LY53857 and ketanserin all very effectively blocked BP responses to m-CPP. These findings suggest that BP and PRA but not vasopressin responses are mediated by 5-HT2 receptors. Vasopressin secretion is mediated by 5-HT1 receptors, most likely by 5-HT1C receptors.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalEuropean Journal of Pharmacology
Volume210
Issue number3
DOIs
Publication statusPublished - Jan 21 1992

Keywords

  • 5-HT receptor agonists
  • 5-HT receptor antagonists
  • 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin)
  • Blood pressure
  • DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)
  • Plasma renin activity
  • Vasopressin
  • m-CPP (1-3-chlorophenyl)piperazine)

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists'. Together they form a unique fingerprint.

  • Cite this